Pregnancy · Diabetes
Insulin in Pregnancy — GDM / T1DM / T2DM
When and how insulin is used in pregnancy — for GDM, T1DM, or T2DM. Glucose targets, injection technique, dose changes through pregnancy, hypos, labour management. Safe for baby (doesn't cross placenta). NICE NG3.
Last reviewed 2 June 2026
Target-driven titration (GDM + T1/T2DM)
Troubleshooting + common pitfalls
- Pitfall: Treating fasting with bolus or post-prandial with basal.
Solution: Match the abnormality to the insulin. Fasting hyperglycaemia → titrate BASAL (long-acting at bedtime). Post-prandial → BOLUS (rapid-acting with the offending meal). Mixing these up is the #1 outpatient error. - Pitfall: Using non-preferred insulin analogues.
Solution: NICE NG3 + ADA: insulin aspart, lispro, NPH, and detemir are preferred in pregnancy. Glargine (older U-100) was historically avoided; current data show safe — discuss with team. Degludec data still emerging. - Pitfall: Continuing oral agents other than metformin.
Solution: T2DM patients should stop sulphonylureas, DPP-4, SGLT2, GLP-1 preconception. Metformin and insulin are the safe options. SGLT2 inhibitors specifically — risk of fetal renal injury. - Pitfall: Not increasing dose through gestation.
Solution: Insulin requirements RISE through pregnancy (~50–100 % increase by 3rd trimester) due to placental hormones. Re-titrate every 1–2 weeks. A “stable” dose late in pregnancy may mean inadequate control. - Pitfall: Sudden dose drop at delivery missed.
Solution: Insulin needs FALL ~50 % immediately after placental delivery. Stop or halve the insulin infusion (T1DM) or insulin doses (T2DM/GDM) at delivery. GDM patients usually need no insulin postpartum. - Pitfall: Glibenclamide as first-line for GDM.
Solution: NICE no longer recommends. Higher rates of neonatal hypoglycaemia and macrosomia vs insulin (Camelo Castillo 2015). Metformin first, insulin second; glibenclamide only if both unsuitable. - Pitfall: No HbA1c at booking for women with risk factors.
Solution: HbA1c at first antenatal visit identifies unrecognised pre-existing diabetes (HbA1c ≥ 6.5 % at booking = T2DM, not GDM — different management pathway). - Pitfall: Aiming for euglycaemia at any cost.
Solution: Aggressive control causes hypoglycaemia, especially in T1DM. Balance: target < 95 fasting / < 140 1-hr, while avoiding severe hypoglycaemia (< 3.0 mmol/L / 54 mg/dL). - Pitfall: Forgetting fetal surveillance.
Solution: T1/T2DM and poorly-controlled GDM need detailed anatomy + echo at 18–22 wk, EFW growth scans q4 wk from 28 wk, and 1–2 weekly CTGs/biophysicals from 32–36 wk depending on control. Aspirin 150 mg from 12 wk for PE prophylaxis. - Pitfall: No postpartum follow-up for GDM.
Solution: ~50 % of GDM women develop T2DM within 10 years. Re-test with 75 g OGTT at 6–12 weeks postpartum + annual HbA1c thereafter. Lifestyle counselling (weight, exercise, diet) is the prevention message. - Pitfall: Macrosomia accepted without GDM review.
Solution: EFW > 90th centile in a known GDM patient should trigger glycaemic-control review (HbA1c, 7-day glucose diary) and potentially intensification. If despite optimal control, plan delivery 37+0–38+6 wk per ACOG 201. - Pitfall: DKA missed in a T1DM mother.
Solution: DKA occurs at lower glucose levels in pregnancy (often < 200 mg/dL / < 11 mmol/L). Suspect with ketonuria, nausea/vomiting, abdominal pain — check capillary ketones and pH urgently. Treatment is fixed-rate IV insulin with K+ replacement and fluids.
Will I definitely need insulin with GDM?
Not necessarily. ~70% of women with GDM control with diet + exercise ± metformin. ~30% need insulin.
NICE NG3 pathway:
- Diet + monitoring 1-2 weeks.
- Add metformin if not meeting targets.
- Add insulin if still not at target OR fasting glucose very high at diagnosis OR macrosomic baby on scan.
Pregnancy glucose targets
- Fasting / pre-meal: <5.3 mmol/L (95 mg/dL).
- 1h after meals: <7.8 mmol/L (140 mg/dL).
- 2h after meals: <6.4 mmol/L (115 mg/dL).
- HbA1c: <48 mmol/mol (6.5%) ideally.
Tighter than non-pregnant ranges — every 1 mmol/L higher = bigger baby.
Types of insulin used in pregnancy
- Rapid-acting (with meals): NovoRapid (aspart), Humalog (lispro), Apidra (glulisine).
- Long-acting (basal): NPH (Humulin I, Insulatard) — most recommended; Levemir (detemir); Lantus sometimes.
- Pump therapy: continued for T1DM women if previously used.
Injection technique
- Pinch skin gently.
- Insert needle at 90° (or 45° if thin).
- Inject slowly over 6-10 seconds.
- Withdraw needle.
- Rotate sites: abdomen (around — not on — belly button), upper outer thigh, back of upper arm.
Single-use needles, sharps bin. Shorter needles (4-6 mm) generally sufficient.
Safe for baby?
Yes. Insulin does NOT cross the placenta. Safe throughout pregnancy + breastfeeding. What harms baby is high maternal glucose — insulin prevents this.
Why dose keeps changing
Placental hormones increase through pregnancy → more insulin resistance. Needs typically increase 2-3 times pre-pregnancy doses by third trimester.
- Peak at 34-36 weeks.
- May plateau or drop in last 2-3 weeks (placenta ageing).
- Sharp drop postpartum — hypo risk; doses often halve immediately.
Hypos (low blood sugar)
Hypo = <4.0 mmol/L (72 mg/dL). Symptoms: shaking, sweating, hunger, confusion.
15-15 rule:
- Take 15g fast-acting carb (4 Lift tablets, 200ml juice, 4 jelly babies).
- Wait 15 minutes.
- Recheck glucose.
- If still <4, repeat.
- Once >4, eat slow carb (toast) to prevent recurrence.
Severe hypo (can’t help yourself): IM glucagon — partner trained.
Delivery timing
- Well-controlled GDM: 39-40 weeks.
- Poorly controlled GDM: 37-38 weeks.
- Insulin-requiring GDM: 38-39 weeks.
- T1DM / T2DM: 37-38+6 weeks (NICE NG3).
- C-section if EFW ≥4.5 kg.
Labour insulin management
- IV insulin sliding scale + dextrose infusion.
- Hourly capillary glucose checks.
- Target 4-7 mmol/L throughout.
- Postpartum: GDM insulin stops; T1DM dose drops ~50%; T2DM may stop or reduce.
Breastfeeding with insulin
Strongly encouraged — compatible. Stabilises glucose; reduces baby’s future diabetes risk; reduces mum’s T2DM risk.
Antenatal colostrum harvesting from 36-37 wk (if advised). Early skin-to-skin. Lactation consultant invaluable.
Different scenarios — insulin in pregnancy
Scenario 1: GDM 28 weeks, fasting 6.0, post-meal 8.5
Diet + monitoring 1-2 weeks. If still high, metformin. If still high, add evening NPH insulin for fasting glucose.
Scenario 2: T1DM on pump, planning pregnancy
Preconception HbA1c <48 mmol/mol. Folic acid 5 mg. Continue pump. Specialist diabetes pregnancy clinic from positive test.
Scenario 3: GDM on insulin, hypo at 2 am
15-15 rule. Bedtime snack at next attempt (yoghurt + toast). Review with team — evening insulin may need reducing.
Scenario 4: 38 weeks, EFW 4.6 kg, GDM on insulin
C-section discussed per NICE NG3. Plan timing carefully. Continue insulin until day of delivery; sliding scale intrapartum.
Scenario 5: Postpartum day 2, GDM mum, glucose 7.5
Insulin stopped after delivery. Glucose may be slightly raised first few days. Continue monitoring 24-48h, then less. 6-12 week OGTT scheduled.
Care guidance — insulin in pregnancy
- Glucose monitoring 4-7x/day.
- Tighter targets than non-pregnant.
- Rotate injection sites.
- Doses increase 2-3x by 3rd trimester.
- Sharp drop postpartum — halve doses.
- Bedtime snack if nighttime hypos.
- Glucose tablets on you always.
- Severe hypo — partner glucagon training.
- Ketones check if glucose >12 or unwell.
- Exercise beneficial — check glucose before.
- Antenatal colostrum from 36-37 wk if advised.
- Postpartum follow-up: 6-12 wk OGTT for GDM.
Sources
- NICE NG3. Diabetes in pregnancy: management.
- ACOG Practice Bulletin 201. Pregestational diabetes mellitus.
- ACOG Practice Bulletin 190. Gestational diabetes mellitus.
- Diabetes UK. Pregnancy and diabetes guides.
- JDRF. Type 1 diabetes and pregnancy.
Recommended for this calculator